Paper
24 March 2023 Breast Cancer Treatment: Adoptive Immunotherapy, Combination Therapy, and Future Perspectives
Xinyue Jian, Shuwen Ge
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 1261141 (2023) https://doi.org/10.1117/12.2669027
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
Breast cancer (BC) has become the first female malignant tumor in the world, and the age of onset is younger, posing a major threat to women's health. In recent years, immunotherapy has made many outstanding achievements in the field of cancer, and many experts in the field of breast cancer have also turned their attention to breast cancer immunotherapy. This article will briefly introduce the relevant situation of breast cancer, focus on the research of much adoptive immunotherapy (CAR T-cell, TIL, NK-cell, TCR-T et.al) in the treatment of BC, and introduce the related combination therapy of breast cancer combined with traditional treatment. Finally, the development and application of BC immunotherapy are prospected. With the vigorous development of immunotherapy, it will be instructive for researchers, therapists, and patients to master the cutting-edge knowledge of immunotherapy for diseases in their field, and the war on cancer will increase the hope of winning.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Xinyue Jian and Shuwen Ge "Breast Cancer Treatment: Adoptive Immunotherapy, Combination Therapy, and Future Perspectives", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 1261141 (24 March 2023); https://doi.org/10.1117/12.2669027
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Cancer

Breast cancer

Radiotherapy

Chemotherapy

Defense systems

Oncology

Back to Top